Praxsyn Corp PXYN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $634.67
- Volume/Avg
- 653,390 / 914,280
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 75
- Website
- http://www.praxsyncorp.com
Valuation
|
Metric
|
PXYN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
PXYN
Financial Strength
|
Metric
|
PXYN
|
|---|---|
Quick Ratio | 0.41 |
Current Ratio | 0.43 |
Interest Coverage | 2.27 |
Quick Ratio
PXYN
Profitability
|
Metric
|
PXYN
|
|---|---|
Return on Assets (Normalized) | −2.87% |
Return on Equity (Normalized) | −18.20% |
Return on Invested Capital (Normalized) | 69.14% |
Return on Assets
PXYN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Dwqqhslct | Rbvw | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Lvszvqbtv | Vtmmvc | $68.1 Bil | |
HLN
| Haleon PLC ADR | Hqysxzzlg | Qdpq | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vhgxpvrm | Qzlts | $14.3 Bil | |
VTRS
| Viatris Inc | Jfzshpcgx | Rccp | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Rjwzcbbh | Thkr | $12.0 Bil | |
CTLT
| Catalent Inc | Zwmlkpst | Rzgxtxk | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Pbthnsj | Yht | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Fgpnkcjs | Lrp | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wddrrlph | Gmrbgng | $3.4 Bil |